Viability of long-term gene therapy in the cochlea

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Atkinson, Patrick J ^a,b   Wise, Andrew K ^a,b   Flynn, Brianna O ^a   Nayagam, Bryony A ^a,b   Richardson, Rachael T ^a,b  

^a Bionics Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3;

ADENOVIRIDAE; ANIMAL; CELL SURVIVAL; COCHLEA; CORTI ORGAN; DEAFNESS; DISEASE MODEL; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; MALE; METABOLISM; PATHOLOGY; PIG; REPORTER GENE; SPIRAL GANGLION; TIME;

ADENOVIRIDAE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; COCHLEA; DEAFNESS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC THERAPY; GENETIC VECTORS; MALE; NERVE GROWTH FACTORS; NEUROTROPHIN 3; ORGAN OF CORTI; SPIRAL GANGLION; SWINE; TIME FACTORS;

EID: 84899052203     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04733     Document Type: Article

References (29)

1. LeWitt, P. A. et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10, 309-319, doi:10.1016/S1474-4422(11)70039-4 (2011).
2. Luo, J. et al. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science 298, 425-429, doi:10.1126/science.1074549 (2002). (Pubitemid 35176353)
3. Ashtari, M. et al. The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest 121, 2160-2168, doi:10.1172/JCI57377 (2011).
4. Maguire, A. M. et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358, 2240-2248, doi:10.1056/NEJMoa0802315 (2008). (Pubitemid 351724453)
5. Akil, O. et al. Restoration of hearing in the VGLUT3 knockoutmouse using virally mediated gene therapy. Neuron 75, 283-293, doi:10.1016/j.neuron.2012.05. 019 (2012).
6. Izumikawa, M. et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 11, 271-276 (2005). (Pubitemid 40460554)
7. Wise, A. K. et al. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18, 1111-1122, doi:10.1038/mt.2010.28 (2010).
8. Wise, A. K. et al. The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection. Hear Res 278, 69-76, doi:10.1016/j.heares.2011.04.010 (2011).
9. Bankiewicz, K. S. et al. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14, 564-570, doi:10.1016/j.ymthe.2006.05.005 (2006). (Pubitemid 44296090)
10. Atkinson, P. J. et al. Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness. PLoS One 7, e52338, doi:10.1371/journal.pone. 0052338 (2012).
11. Shibata, S. B. et al. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp Neurol 223, 464-472, doi:10.1016/j.expneurol.2010.01.011 (2010).
12. Sly, D. J. et al. Deafness alters auditory nerve fibre responses to cochlear implant stimulation. Eur J Neurosci 26, 510-522 (2007). (Pubitemid 47087620)
13. Wise, A. K. et al. Combining cell-based therapies and neural prostheses to promote neural survival. Neurotherapeutics: the journal of the American Society for Experimental Neuro Therapeutics 8, 774-787, doi:10.1007/s13311-011- 0070-0 (2011).
14. Taylor, R. R., Jagger, D. J. & Forge, A. Defining the cellular environment in the organ of Corti following extensive hair cell loss: a basis for future sensory cell replacement in the Cochlea. PLoS One 7, e30577, doi:10.1371/journal.pone.0030577 (2012).
15. Liu, Y. et al. Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea. Mol Ther 16, 474-480 (2008). (Pubitemid 351314985)
16. Ruan, R. S., Leong, S. K., Mark, I. & Yeoh, K. H. Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment. Neuroreport 10, 2067-2071 (1999). (Pubitemid 29394049)
17. Saberan-Djoneidi, D. et al. Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene 248, 223-231 (2000). (Pubitemid 30259433)
18. Nadol, J. B., Jr. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation. Otolaryngol Head Neck Surg 117, 220-228 (1997).
19. Nadol, J. B., Jr., Young, Y. S. & Glynn, R. J. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 98, 411-416. (1989). (Pubitemid 19157734)
20. Otte, J., Schuknecht, H. F. & Kerr, A. G. Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. Laryngoscope 88, 1231-1246 (1978).
21. Agterberg, M., Versnel, H., van Dijk, L., de Groot, J.&Klis, S. Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea Pigs. J Assoc Res Otolaryngol 10, 355-367 (2009).
22. Gillespie, L. N., Clark, G. M., Bartlett, P. F. & Marzella, P. L. BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects. J. Neurosci. Res. 71, 785-790 (2003). (Pubitemid 36292998)
23. Pettingill, L. N., Wise, A. K., Geaney, M. S. & Shepherd, R. K. Enhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig. PLoS One 6, e18733, doi:10.1371/journal.pone.0018733 (2011).
24. Tan, J. et al. Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration. Adv Mater 24, 3362-3366, doi:10.1002/adma.201200634 (2012).
25. James, D. P., Eastwood, H., Richardson, R. T. & O'Leary, S. J. Effects of Round Window Dexamethasone on Residual Hearing in a Guinea PigModel of Cochlear Implantation. Audiol Neurootol 13, 86-96 (2008). (Pubitemid 351225887)
26. Backhouse, S., Coleman, B. & Shepherd, R. Surgical access to the mammalian cochlea for cell-based therapies. Exp Neurol 214, 193-200 (2008).
27. Shepherd, R. K., Coco, A., Epp, S. B. & Crook, J. M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 486, 145-158 (2005). (Pubitemid 40571697)
28. Richardson, R. T. et al. Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30, 2614-2624 (2009).
29. Wise, A. K., Richardson, R., Hardman, J., Clark, G. & O'Leary, S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 487, 147-165 (2005). (Pubitemid 40734116)